Wei Guo

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 2

Top Topics

Breast Cancer Risk

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Lanlin Yao, Xuejun Wen, Wei Guo, Jianyang Fang, Xianzhong Zhang, Zhide Guo, Jinxiong Huang, Yesen Li
Novel Radiolabeled TMTP1 for Long-Acting Hepatocellular Carcinoma Therapeutics. Molecular pharmaceutics 19 (9) (2022)
Lanlin Yao, Yesen Li, Haojun Chen, Xuejun Wen, Yizhen Pang, Zijun Chen, Zhide Guo, Xianzhong Zhang, Hua Wu, Wei Guo
Dual Targeting of Integrin α v β 3 and Neuropilin-1 Receptors Improves Micropositron Emission Tomography Imaging of Breast Cancer. Molecular pharmaceutics 19 (5) (2022)